selected publications
-
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.
Osteoarthritis and cartilage.
2021
Academic Article
GET IT
Times cited: 34 -
US rheumatologists' beliefs and knowledge about biosimilars: a survey.
Rheumatology (Oxford, England).
2021
Academic Article
GET IT
Times cited: 19 -
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey.
RMD open.
2020
Academic Article
GET IT
Times cited: 21 -
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial.
Arthritis & rheumatology (Hoboken, N.J.).
2020
Academic Article
GET IT
Times cited: 69 -
Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
2020
Academic Article
GET IT
Times cited: 4 -
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists.
Seminars in arthritis and rheumatism.
2020
Academic Article
GET IT
Times cited: 10 -
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis.
The Journal of rheumatology.
2019
Academic Article
GET IT
Times cited: 12 - A better look at rheumatoid arthritis: Using imaging to improve patient outcomes. Seminars in arthritis and rheumatism. 2018 Academic Article GET IT
-
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys.
Health and quality of life outcomes.
2018
Academic Article
GET IT
Times cited: 26 -
Short-term costs associated with non-medical switching in autoimmune conditions.
Clinical and experimental rheumatology.
2018
Academic Article
GET IT
Times cited: 14 -
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study.
Clinical rheumatology.
2018
Academic Article
GET IT
Times cited: 19 -
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.
Arthritis care & research.
2018
Academic Article
GET IT
Times cited: 23 -
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors.
Current medical research and opinion.
2017
Academic Article
GET IT
Times cited: 15 -
Down-titration of biologics for the treatment of rheumatoid arthritis: a systematic literature review.
Rheumatology international.
2017
Review
GET IT
Times cited: 20 -
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.
Osteoarthritis and cartilage.
2017
Academic Article
GET IT
Times cited: 93 -
Sex differences in gout characteristics: tailoring care for women and men.
BMC musculoskeletal disorders.
2017
Academic Article
GET IT
Times cited: 35 -
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial.
Clinical rheumatology.
2017
Academic Article
GET IT
Times cited: 3 -
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
Current medical research and opinion.
2015
Academic Article
GET IT
Times cited: 20 -
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.
Scandinavian journal of rheumatology.
2015
Academic Article
GET IT
Times cited: 13 -
Low-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis pain.
Expert opinion on drug safety.
2015
Review
GET IT
Times cited: 5 -
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Annals of the rheumatic diseases.
2015
Conference Paper
GET IT
Times cited: 956 -
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.
Postgraduate medicine.
2015
Academic Article
GET IT
Times cited: 9 -
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
Clinical and experimental rheumatology.
2015
Academic Article
GET IT
Times cited: 5 -
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network.
BMC musculoskeletal disorders.
2014
Academic Article
GET IT
Times cited: 12 -
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
Current medical research and opinion.
2014
Academic Article
GET IT
Times cited: 27 -
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.
Clinical rheumatology.
2014
Review
GET IT
Times cited: 20 -
Current therapeutic agents and treatment paradigms for the management of rheumatoid arthritis.
The American journal of managed care.
2014
Review
GET IT
Times cited: 14 -
Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis.
The American journal of managed care.
2014
Academic Article
GET IT
Times cited: 160 -
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.
Postgraduate medicine.
2013
Academic Article
GET IT
Times cited: 23 - Proceedings of the 2013 Rheumatology Winter Clinical Symposia. Seminars in arthritis and rheumatism. 2013 Review GET IT
-
Delayed-release prednisone - a new approach to an old therapy.
Expert opinion on pharmacotherapy.
2013
Review
GET IT
Times cited: 14 -
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.
Annals of the rheumatic diseases.
2013
Conference Paper
GET IT
Times cited: 100 - The times they are a changin'. Rheumatology (Oxford, England). 2013 Editorial Article GET IT
-
Comparative effectiveness of current treatments for rheumatoid arthritis.
The American journal of managed care.
2012
Academic Article
GET IT
Times cited: 16 -
Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis.
The American journal of managed care.
2012
Academic Article
GET IT
Times cited: 318 -
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.
Annals of the rheumatic diseases.
2012
Conference Paper
GET IT
Times cited: 99 -
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement.
Annals of the rheumatic diseases.
2012
Review
GET IT
Times cited: 72 -
A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac.
Pain medicine (Malden, Mass.).
2012
Academic Article
GET IT
Times cited: 19 -
Need to develop new nonsteroidal anti-inflammatory drug formulations.
Clinical therapeutics.
2012
Review
GET IT
Times cited: 37 -
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.
Annals of the rheumatic diseases.
2012
Conference Paper
GET IT
Times cited: 81 -
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry.
Annals of the rheumatic diseases.
2012
Academic Article
GET IT
Times cited: 125 -
The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
Postgraduate medicine.
2012
Academic Article
GET IT
Times cited: 21 -
Minimizing cardiovascular complications during the treatment of osteoarthritis.
American journal of therapeutics.
2011
Review
GET IT
Times cited: 2 - Erratum to: Treating rheumatoid arthritis to target: an international initiative. Current reviews in musculoskeletal medicine. 2011 Academic Article GET IT
-
Treating rheumatoid arthritis to target: an international initiative.
Current reviews in musculoskeletal medicine.
2011
Academic Article
GET IT
Times cited: 72 -
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire.
Annals of the rheumatic diseases.
2011
Academic Article
GET IT
Times cited: 69 -
Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry.
The Journal of rheumatology.
2011
Academic Article
GET IT
Times cited: 74 -
Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?.
Current opinion in rheumatology.
2011
Review
GET IT
Times cited: 26 -
Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database.
Osteoarthritis and cartilage.
2011
Review
GET IT
Times cited: 42 -
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010.
Annals of the rheumatic diseases.
2011
Conference Paper
GET IT
Times cited: 80 -
Musculoskeletal manifestations of thyroid disease.
Rheumatic diseases clinics of North America.
2010
Review
GET IT
Times cited: 32 -
Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries.
The Journal of rheumatology.
2010
Academic Article
GET IT
Times cited: 15 -
Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes.
Annals of the rheumatic diseases.
2010
Editorial Article
GET IT
Times cited: 14 -
Treating rheumatoid arthritis to target: recommendations of an international task force.
Annals of the rheumatic diseases.
2010
Conference Paper
GET IT
Times cited: 1572 -
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.
Annals of the rheumatic diseases.
2010
Conference Paper
GET IT
Times cited: 129 -
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
Annals of the rheumatic diseases.
2008
Conference Paper
GET IT
Times cited: 106 -
Pay for performance in rheumatology: will we get the carrot or the stick?.
Arthritis and rheumatism.
2008
Editorial Article
GET IT
Times cited: 2 -
The role of drug and disease registries in rheumatic disease epidemiology.
Current opinion in rheumatology.
2008
Review
GET IT
Times cited: 27 -
Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic.
American journal of therapeutics.
2008
Review
GET IT
Times cited: 15 -
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.
Current rheumatology reports.
2008
Review
GET IT
Times cited: 18 -
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis.
Current pain and headache reports.
2007
Review
GET IT
Times cited: 6 -
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Clinical therapeutics.
2007
Academic Article
GET IT
Times cited: 11 -
Improving survival in inflammatory rheumatic diseases: a neglected goal?.
Current rheumatology reports.
2006
Academic Article
GET IT
Times cited: 1 -
Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C.
2006
GET IT
Times cited: 22 -
Combination therapy for rheumatoid arthritis in the era of biologicals.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery.
2006
Academic Article
GET IT
Times cited: 441 -
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Current medical research and opinion.
2006
Academic Article
GET IT
Times cited: 62 -
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Current medical research and opinion.
2006
Academic Article
GET IT
Times cited: 45 -
An analysis of recent antitrust issues affecting specialty practice: is dermatology immune?.
Seminars in cutaneous medicine and surgery.
2005
Academic Article
GET IT
Times cited: 1 -
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis.
Annals of the rheumatic diseases.
2004
Academic Article
GET IT
Times cited: 153 -
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
Arthritis and rheumatism.
2003
Academic Article
GET IT
Times cited: 54 -
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
Annals of the rheumatic diseases.
2003
Conference Paper
GET IT
Times cited: 80 -
If I am not for myself, who will be for me?.
Arthritis and rheumatism.
2003
Conference Paper
GET IT
Times cited: 2 -
Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
2002
Review
GET IT
Times cited: 4 -
Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists.
Arthritis and rheumatism.
2002
Editorial Article
GET IT
Times cited: 94 - American College of Rheumatology. Journal of the Medical Association of Georgia. 2002 Academic Article GET IT
- Clinical Images:Lupus erythematosus cells in the kidney and synovial fluid. 2001 GET IT
-
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice.
The Journal of rheumatology.
2000
Editorial Article
GET IT
Times cited: 48 -
A diagnostic approach to musculoskeletal pain.
Clinical cornerstone.
1999
Academic Article
GET IT
Times cited: 4 -
Rheumatic fever. The relationships between host, microbe, and genetics.
Rheumatic diseases clinics of North America.
1998
Review
GET IT
Times cited: 42 -
The arthritogenic properties of microbial antigens. Their implications in disease states.
Rheumatic diseases clinics of North America.
1998
Review
GET IT
Times cited: 2 -
The co-occurrence of acute rheumatic fever and AIDS.
1997
GET IT
Times cited: 2 -
Liability issues in the treatment of patients with rheumatic diseases.
The American journal of medicine.
1997
Review
GET IT
Times cited: 1 -
Legal issues in allergy and clinical immunology.
The Journal of allergy and clinical immunology.
1996
Review
GET IT
Times cited: 3 -
Rheumatic fever and poststreptococcal reactive arthritis.
Current opinion in rheumatology.
1995
Review
GET IT
Times cited: 22 -
Marriage, social support, and adjustment to rheumatic disease.
Bulletin on the rheumatic diseases.
1995
Review
GET IT
Times cited: 24 -
Scleroderma in women with silicone breast implants: comment on the article by Sánchez-Guerrero et al.
Arthritis and rheumatism.
1995
Letter
GET IT
Times cited: 6 -
Risk management in endoscopic practice.
Gastrointestinal endoscopy clinics of North America.
1995
Review
GET IT
Times cited: 1 - Medicare fraud regulations and the implications for joint ventures: are we working at cross purposes?. Legal medicine. 1995 Academic Article GET IT
- Breast implants and connective-tissue diseases. The New England journal of medicine. 1994 Letter GET IT
-
Systemic lupus erythematosus presenting as a non-O:1 Vibrio cholerae abscess.
1994
GET IT
Times cited: 5 -
The developing application of antitrust laws to hospital mergers.
The Journal of legal medicine.
1994
Academic Article
GET IT
Times cited: 2 -
Silicone gel filled breast implants and connective tissue disease: an overview.
The Journal of rheumatology.
1994
Review
GET IT
Times cited: 65 -
Rheumatic fever: new insights into an old disease.
Bulletin on the rheumatic diseases.
1993
Review
GET IT
Times cited: 7 - The Americans with Disabilities Act of 1990--changes in existing protection and impact on the private health services provider. Legal medicine. 1993 Academic Article GET IT
- The role of professional education in improving quality of life. Arthritis care and research : the official journal of the Arthritis Health Professions Association. 1992 Editorial Article GET IT
-
The Americans with Disabilities Act of 1990. Changes in existing protection and impact on the private health services provider.
The Journal of legal medicine.
1992
Review
GET IT
Times cited: 3 - Etiology and genetics of collagen diseases. Clinics in dermatology. 1992 Review GET IT
-
Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis.
Arthritis care and research : the official journal of the Arthritis Health Professions Association.
1991
Academic Article
GET IT
Times cited: 89 -
The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease.
The Journal of rheumatology. Supplement.
1991
Review
GET IT
Times cited: 63 -
Social support as a double-edged sword: the relation of positive and problematic support to depression among rheumatoid arthritis patients.
Social science & medicine (1982).
1991
Academic Article
GET IT
Times cited: 330 -
Rheumatic fever.
Current opinion in rheumatology.
1989
Review
GET IT
Times cited: 3 -
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.
The Journal of clinical investigation.
1989
Academic Article
GET IT
Times cited: 147 -
Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
Current topics in microbiology and immunology.
1989
Review
GET IT
Times cited: 53 -
The role of Fc gamma receptors in mononuclear phagocyte system function.
Clinical and experimental rheumatology.
1989
Review
GET IT
Times cited: 15 - AIDS. Current medical and scientific aspects. The Journal of legal medicine. 1988 Review GET IT
-
Regulatory and legal issues in the reprocessing and reuse of hemodialyzers. A critical overview.
The Journal of legal medicine.
1988
Review
GET IT
Times cited: 4 -
Genetics of the Hajdu-Cheney syndrome.
Arthritis and rheumatism.
1987
Letter
GET IT
Times cited: 4 -
Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc gamma receptor specific.
Journal of immunology (Baltimore, Md. : 1950).
1986
Academic Article
GET IT
Times cited: 21 -
Methyldopa and reticuloendothelial function.
The New England journal of medicine.
1986
Letter
GET IT
Times cited: 1 -
Genetic control of the susceptibility to infection with pathogenic bacteria.
Current topics in microbiology and immunology.
1986
Review
GET IT
Times cited: 8 -
Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
Journal of immunology (Baltimore, Md. : 1950).
1984
Academic Article
GET IT
Times cited: 79 -
Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2.
The American review of respiratory disease.
1983
Academic Article
GET IT
Times cited: 32 -
Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults.
The Journal of experimental medicine.
1983
Academic Article
GET IT
Times cited: 32 -
Neonatal lupus erythematosus with heart block: family study of a patient with anti-SS-A and SS-B antibodies.
1983
GET IT
Times cited: 55 -
Familial systemic lupus erythematosus in males.
Arthritis and rheumatism.
1983
Academic Article
GET IT
Times cited: 55 -
Pac-Man phalanx.
Arthritis and rheumatism.
1983
Letter
GET IT
Times cited: 2 -
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis.
Annals of internal medicine.
1982
Academic Article
GET IT
Times cited: 53 -
Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type.
Clinical immunology and immunopathology.
1982
Academic Article
GET IT
Times cited: 86 -
Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.
1981
GET IT
Times cited: 23 -
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.
The Journal of experimental medicine.
1980
Academic Article
GET IT
Times cited: 262 -
Immunopathogenesis of rheumatoid arthritis.
The American journal of medicine.
1979
Review
GET IT
Times cited: 28 -
Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.
Transplantation proceedings.
1979
Academic Article
GET IT
Times cited: 1 -
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis.
Annals of internal medicine.
1979
Academic Article
GET IT
Times cited: 185 -
Association of HLA-DRw2 with autoimmune thrombocytopenic purpura.
The Journal of clinical investigation.
1979
Academic Article
GET IT
Times cited: 45 -
Association of a B-cell alloantigen with susceptibility to rheumatic fever.
Nature.
1979
Academic Article
GET IT
Times cited: 116 -
Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus.
The Journal of experimental medicine.
1978
Academic Article
GET IT
Times cited: 145 -
Expression of Ia-like antigens on cultured human malignant melanoma cell lines.
Proceedings of the National Academy of Sciences of the United States of America.
1978
Academic Article
GET IT
Times cited: 118 -
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus.
Arthritis and rheumatism.
1978
Academic Article
GET IT
Times cited: 39 -
The identification of HL-A antigens on fresh and cultured human endothelial cells.
Journal of immunology (Baltimore, Md. : 1950).
1975
Academic Article
GET IT
Times cited: 18 -
Medium effects for single ions in acetonitrile and ethanol-water solvents based on reference-electrolyte assumption.
Analytical chemistry.
1972
Academic Article
GET IT
Times cited: 82 -
Trypsinization of lymphocytes for HL-A typing.
Transplantation.
1972
Academic Article
GET IT
Times cited: 17